| |
| |
|
| Insider
Information: |
Butchko Julia G. |
| Relationship: |
Chief Development Offi... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
451,627 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
451,627 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunovant Inc |
IMVT |
Chief Development Offi... |
2024-04-17 |
451,627 |
2020-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2024-04-17 |
4 |
S |
$28.80 |
$293,923 |
D/D |
(10,115) |
451,627 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2024-04-09 |
4 |
S |
$31.18 |
$32,833 |
D/D |
(1,053) |
461,742 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,978 |
462,795 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2024-02-22 |
4 |
S |
$36.15 |
$77,578 |
D/D |
(2,146) |
407,817 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2024-01-05 |
4 |
S |
$38.59 |
$50,051 |
D/D |
(1,297) |
409,963 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2023-11-22 |
4 |
S |
$32.75 |
$107,024 |
D/D |
(3,265) |
411,260 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2023-10-05 |
4 |
S |
$35.54 |
$62,885 |
D/D |
(1,735) |
414,525 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2023-08-24 |
4 |
S |
$20.30 |
$250,360 |
D/D |
(12,333) |
416,260 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2023-07-12 |
4 |
S |
$19.73 |
$29,003 |
D/D |
(1,470) |
428,593 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Development Officer |
• – – |
2023-04-18 |
4 |
S |
$15.27 |
$23,577 |
D/D |
(1,544) |
430,063 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2023-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,188 |
431,607 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2023-01-11 |
4 |
S |
$15.16 |
$1,015,596 |
D/D |
(60,490) |
331,419 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-10-13 |
4 |
S |
$9.18 |
$8,519 |
D/D |
(928) |
391,909 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-09-28 |
4 |
S |
$4.67 |
$2,498 |
D/D |
(535) |
392,837 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-08-30 |
4 |
S |
$5.83 |
$3,195 |
D/D |
(548) |
393,372 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
112,816 |
393,920 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-07-27 |
4 |
S |
$4.27 |
$2,178 |
D/D |
(510) |
281,104 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-06-29 |
4 |
S |
$4.02 |
$1,849 |
D/D |
(460) |
281,614 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-05-24 |
4 |
S |
$3.79 |
$1,865 |
D/D |
(492) |
282,074 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-04-27 |
4 |
S |
$4.72 |
$2,554 |
D/D |
(541) |
282,566 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-03-24 |
4 |
S |
$5.90 |
$37,648 |
D/D |
(6,381) |
283,107 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2022-01-07 |
4 |
S |
$7.25 |
$401,056 |
D/D |
(55,318) |
289,488 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
285,306 |
344,806 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
54,500 |
59,500 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Dev. & Tech. Officer |
• – – |
2020-09-11 |
4 |
B |
$38.17 |
$190,850 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
